By analyzing the resistance genes and proteins of E. coli, researchers can optimize treatments to address both current and ...

Drumsheds and the Warehouse Project are implementing discreet "back of house" drug-testing procedures amid a broader push for ...

Need to identify a tablet or capsule? Use our Pill Identifier to find the name and image of an unknown prescription or over-the-counter medication. Start by entering details like pill imprint code ...

Alzheimer's disease—the most common form of dementia—is a progressive neurological disorder that causes brain cells to ...

Integral Molecular, a leader in antibody discovery and characterization, has been awarded $2.7 million by the NIH ...

Drug use among young people in Vietnam is on the rise, with nearly half of all users aged between 12 and 30, according to the ...

Researchers explain how a drug that helps patients with neurological issues walk may also provide a surprising boost for the ...

Despite many warnings of unintended consequences, the PCs are moving ahead with closing down 10 facilities across the ...

Preclinical studies have shown AT-02 is able to bind to multiple amyloid types and can induce macrophage mediated amyloid phagocytosis and removal. The Food and Drug Administration has granted Orphan ...

University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms ...

Hello, Reader. For all that artificial intelligence has accomplished over the last few years, one thing it has not yet ...

GigaGen Inc., a biotechnology company advancing transformative antibody drugs for immunodeficiencies, infectious diseases and checkpoint-resistant cancers, and a subsidiary of Grifols, announced today ...